KRAS and cancer: Cell type-specific Exo proteins are so far most comprehensively explored for cancer and cancer stem cells (CSC), such as MART1, EGFRVIII, multidrug resistance gene 1, EpCAM, MET, mutant KRAS, and tissue factor (73, 85–88).